Latest Capital Raising News

Octava Minerals has secured a binding agreement to acquire the Federation Cu-Zn-Ag Project in Tasmania, reported promising bioleaching test results at its Byro REE-Li Project, and raised $1.5 million to fund exploration and working capital.

Rey Resources reports continued exploration progress in Western Australia's Canning Basin alongside a stable financial footing supported by substantial shareholder loans.

Tennant Minerals has identified a significant copper anomaly at its Bluebird East prospect, mirroring the high-grade Bluebird discovery, while advancing large-scale gold-copper targets at its Barkly Project in the Northern Territory.

Mount Burgess Mining advances metallurgical test work at its Nxuu deposit, navigates leadership changes, and pursues a significant legacy debt extinguishment as it refines its strategic focus.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.

Hydrocarbon Dynamics Limited reported ongoing sales and expanded trials of its HCD Multi-Flow product worldwide, alongside plans for a fully underwritten rights issue to bolster its financial position.

Saturn Metals has reported a robust June quarter highlighted by significant drilling success and exceptional metallurgical recoveries at Apollo Hill, lifting its gold resource to 2.24 million ounces. These developments set the stage for a pivotal Pre-Feasibility Study and maiden Ore Reserve later this year.

Mithril Silver and Gold reports outstanding high-grade gold and silver assay results from its Copalquin district in Mexico, setting the stage for an extensive drilling campaign starting August 2025. The discovery at Target 6 expands the district’s promising resource potential.

Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.

Resolution Minerals Limited is set to pursue a dual-listing on the NASDAQ in Q4 2025, aiming to tap into deeper U.S. capital markets and enhance its profile among American investors. The move supports the development of its critical minerals Horse Heaven project in Idaho, aligning with U.S. national security interests.

ActivEX Limited reports a maiden gold resource of 310,000 ounces at its Gilberton project and broadens its rare earth element exploration with new tenement applications in Queensland.